Chemical Compound
(1R,2R,4S)-4-{(2R)-2-[(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,30S,34aS)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontin-3-yl]propyl}-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate
CAS Registry Number
162635-04-3
Primary record
(1R,2R,4S)-4-{(2R)-2-[(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,30S,34aS)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontin-3-yl]propyl}-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate
- 库存
- 1,462 克
- 纯度
- 99.3 %
- CAS
- 162635-04-3
化合物标识与属性
- CAS
- 162635-04-3
- PubChem CID
- 6918289
- SMILES
- C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OC(=O)C(C)(CO)CO)C)/C)O)OC)C)C)/C)OC
- Canonical SMILES
- CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C
名称与同义词
- Temsirolimus
- Torisel
- CCI-779
- temsirolimusum
- Temserolimus
- Temsorolimus
- Temsirolimus?
- Temsirolimus Injection
- Temsirolimus [USAN]
- 162635-04-3
- Temsirolimus - Torisel
- RefChem:56883
- Temsirolimus (>80%)
- Cci 779
- 624KN6GM2T
- TEMSIROLIMUS [MI]
- Temsirolimus(CCI-779)
- DTXSID2040945
- TEMSIROLIMUS [INN]
- TEMSIROLIMUS [JAN]
- TEMSIROLIMUS [VANDF]
- UNII-624KN6GM2T
- MFCD00934421
- CHEMBL1201182
- DTXCID0020945
- TEMSIROLIMUS [MART.]
- TEMSIROLIMUS [WHO-DD]
- WAY-CCI 779
- C56H87NO16
- GTPL5892
- orb1306354
- TEMSIROLIMUS [EMA EPAR]
- HSDB 7931
- L01XE09
- Temsirolimus, >=98% (HPLC)
- CBPNZQVSJQDFBE-FUXHJELOSA-N
- GLXC-90175
- TEMSIROLIMUS [ORANGE BOOK]
- AOB87306
- Temsirolimus [USAN:INN:BAN:JAN]
- Tox21_112515
- BDBM50343413
- NCGC00167518-01
- s1044
- AKOS025142069
- AM84554
- CCG-264790
- CS-0129
- FR61494
- NSC 683864
- NSC-683864
- RL02091
- SDCCGSBI-0654330.P001
- NCGC00167518-02
- NCGC00167518-05
- NCGC00167518-09
- Rapamycin 42-(2,2-bis(hydroxymethyl)propionate)
- HY-50910
- RT-015903
- Temsirolimus (CCI-779, NSC 683864)
- A8314
- CAS-162635-04-3
- T3574
- AB01274736-01
- AB01274736_02
- 635T043
- Rapamycin, 42-(3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate)
- SR-01000898799
- Q7699074
- SR-01000898799-3
- BRD-K08177763-001-02-6
- Rapamycin 42-[3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate]
- 42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]-rapamycin
- Rapamycin 42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate
- (1R,2R,4S)-4-{(2R)-2-[(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,30S,34aS)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontin-3-yl]propyl}-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate
- ((1R,2R,4S)-4-((2R)-2-((1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraen-12-yl)propyl)-2-methoxycyclohexyl) 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate
- (1R,2R,4S)-4-{(2R)-2-[(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontin-3-yl]propyl}-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate
- (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone 4'-(2,2-bis(hydroxymethyl)propionate)
- [(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxy-cyclohexyl] 3-hydroxy-2-(hydroxymethyl)-2-methyl-propanoate
- [(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate
- [(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoateEE
- A4I
- Rapamycin, 42-[3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate]; 40-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]-rapamycin; CCI 779; Temsirolimus; Temsorolimus; Torisel; WAY-CCI 779